Our study suggests that patients with higher expression of PDGFRb might have an increased risk of any breast cancer recurrence, but due to correlation with younger age and ER negativity, a function of PDGFRb as independent prognostic marker could not be demonstrated. The gene discussed is ESR1; the disease is breast cancer.